Neurostimulation Devices Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 17.49 Billion by 2030: Verified Market Research®

0
124

Summation

  • Furthermore, with factors such as a growing number of neurological cases and lifestyle diseases, increasing investment from governments, and the rising focus on research and development, the market for neurostimulators is estimated to expand further.
  • Overall, the neurostimulation devices market is expected to witness strong growth in the coming years due to the rising number of neurological cases and the increasing adoption of minimally invasive surgeries.
  • , April 28, 2023 /PRNewswire/ — The Global Neurostimulation Devices Market is projected to grow at a CAGR of 12.

The “Global Neurostimulation Devices Market Size By Devices Type (Implantable Devices, External Devices), By Application (Parkinson’s Disease, Epilepsy), By End-User (Rehabilitation Centers, Hospitals), By Geographic Scope & Forecast, 2023-2030” report has been published by Verified Market Research®. The report provides an in-depth analysis of the global Neurostimulation Devices Market, including its growth prospects, market trends, and market challenges

JERSEY CITY, N. J., April 28, 2023 /PRNewswire/ — The Global Neurostimulation Devices Market is projected to grow at a CAGR of 12.50% from 2023 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 6.06 Billion in 2021 and is expected to reach USD 17.49 Billion by the end of the forecast period.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=3588

Browse in-depth TOC onNeurostimulation Devices Market

202 – Pages
126 – Tables
37 – Figures

Global Neurostimulation Devices Market to Witness Rapid Growth due to Rising Geriatric Population

The global market for neurostimulation devices is set to witness rapid growth in the coming years. The use of neurostimulation devices has gained prominence in recent years due to their ability to relieve pain in patients suffering from the loss of sense and paralysis. These devices work by disrupting the neural signals between the brain and spinal cord, thus restricting the pain sensation. As a result, neurostimulation devices are increasingly being administered as an alternative to potent painkillers, except opiates.

The market for neurostimulators is mainly growing with the increase in the global geriatric population that is highly prone to neurological diseases like migraine and epilepsy. In diseases such as movement disorders, epilepsy, Parkinson’s disease, chronic pain, and depression, neurostimulation devices can be of great help. Furthermore, with factors such as a growing number of neurological cases and lifestyle diseases, increasing investment from governments, and the rising focus on research and development, the market for neurostimulators is estimated to expand further.

Some of the key players in the neurostimulation devices market include Boston Scientific Corporation, St. Jude Medical, Inc., Cochlear, Ltd., Medtronic, Plc, NDI Medical, LLC, MED-EL., Cyberonics, Inc. NeuroSigma, Inc., and NeuroPace, Inc. These companies are expected to invest in research and development activities to introduce innovative products that offer better patient outcomes.

The report on the global neurostimulation devices market provides financial statements, product benchmarking and SWOT analysis, key development strategies, market share, and market ranking analysis. The report also covers the latest trends and technologies that are likely to influence the market in the coming years.

Overall, the neurostimulation devices market is expected to witness strong growth in the coming years due to the rising number of neurological cases and the increasing adoption of minimally invasive surgeries. With the introduction of new and innovative products, this market is expected to offer significant opportunities for players operating in this space.

Based on the research, Verified Market Research® has segmented the global Neurostimulation Devices Market into Devices Type, Application, End-User, And Geography.

  • Neurostimulation Devices Market, by Devices Type
    • Implantable Devices
      • Vagus Nerve Stimulators
      • Spinal Cord Stimulators
      • Deep Brain Stimulators
      • Gastric Electric Stimulators
      • Others
    • External Devices
      • Transcranial Magnetic Stimulation (TMS)
      • Transcutaneous Electrical Nerve Stimulation (TENS)
      • Others
  • Neurostimulation Devices Market, by Application
    • Parkinson’s Disease
    • Epilepsy
    • Depression
    • Dystonia
    • Pain Management
    • Others
  • Neurostimulation Devices Market, by End-User
    • Rehabilitation Centers
    • Hospitals
    • Medical Clinics
    • Others
  • Neurostimulation Devices Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Sacral Nerve Stimulation Market By Product (External Sacral Nerve Stimulation, Implantable Sacral Nerve Stimulation), By Application (Urge Incontinence, Urinary And Fecal Incontinence), By End-User (Hospitals/Clinics, Ambulatory Surgical Centers), By Geography, And Forecast

Electrical Bone Growth Stimulators Market By Product (External Type, Implanted Type), By Application (Hospitals And Clinics, Home Care, Academic And Research Institutes), By Geography, And Forecast

Electrical Stimulation Devices Market By Device Type (Sacral Nerve Stimulation Devices, Spinal Cord Stimulation Devices), By Application (Musculoskeletal Disorder Management, Pain Management), By End-User (Hospitals, Ambulatory research centers), By Geography, And Forecast

Muscle Stimulation Devices Market By Type (Neuromuscular Electric Stimulator (NMES), Transcutaneous Electric Nerve Stimulator (TENS)), By Application (Hospitals), By Geography, And Forecast

Top Consumer Healthcare Companies improving consumer lives pole to pole

Visualize Neurostimulation Devices Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.